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890 The Journal of Thoracic and CardioObjective: We studied long-term outcomes in severe aortic stenosis and the impor-
tance of prosthesis type (mechanical vs biologic) and size, preoperative left ven-
tricular ejection fraction, diastolic function, and left ventricular mass.
Methods: Patients undergoing valve replacement from 1991 to 1993 (n  399, 45%
women) were included. The diastolic function was evaluated by integrating mitral
and pulmonary venous flow data with Doppler echocardiography. The patients were
classified as having either normal diastolic function to mild diastolic dysfunction or
moderate to severe diastolic dysfunction. Left ventricular ejection fraction and the
diastolic function category were incorporated together with age, sex, and time since
operation into a Poisson regression model with death as the end point. Prosthesis
type and size and left ventricular mass were also investigated.
Results: The age (mean  SD) was 71  9 years, and the overall survival after 12
years was 50%. Although markedly reduced during the initial 6-month period,
mortality risk subsequently increased more than could be explained by age (hazard
ratio of 1-year difference  1.12, P  .0005). The moderate to severe diastolic
dysfunction pattern independently predicted late mortality (hazard ratio 1.72, P
.0038), whereas left ventricular ejection fraction did not (hazard ratio  0.99, P 
.18). The prognostic importance of moderate to severe diastolic dysfunction did not
diminish with time; on the contrary, it tended to increase. Mortality after 12 years
was not predicted by left ventricular mass (P  .66), prosthesis type (P  .57), or
prosthesis size (P  .58).
Conclusion: This study reveals that moderate to severe diastolic dysfunction in
patients with aortic stenosis is an independent predictor of late mortality after valve
replacement and that its importance does not decrease with time. Our findings may
suggest that moderate to severe diastolic dysfunction implies nonreversible myo-
cardial changes that negatively affect survival.
According to guidelines, patients with severe aortic stenosis shouldundergo aortic valve replacement if they have symptoms,1 but thetreatment of symptom-free patients is more controversial.2,3 It canbe difficult in clinical practice to distinguish between patientswith and without symptoms, because the progression of stenosis isslow, the patients adapt, and, especially in the case of older
patients, symptoms such as dyspnea are often not recognized and communicated.
Other prognostic factors may therefore play an important part in the decision-
making process.
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CDIn patients with aortic stenosis, several clinical risk fac-
tors have been identified; these include myocardial infarc-
tion, coronary artery disease, atrial fibrillation, congestive
heart failure, and aortic regurgitation.4-6 Patients with aortic
stenosis are known to have left ventricular hypertrophy and
diastolic dysfunction. The type and size of aortic prosthesis
determine the degree of regression of left ventricular mass
(LVM) after aortic valve replacement.7-9 The reduction in
LVM has been shown to be more pronounced with mechan-
ical prostheses than with biologic prostheses and also to be
more pronounced with large prosthetic valves than with
small (21 mm) ones.9 It is therefore an unproven hypoth-
esis that the combination of excessive left ventricular hy-
pertrophy and a small mechanical valve or stented biologic
prosthesis could adversely influence long-term outcome.
In a previous report on prognostic factors of importance
for early mortality, we found that moderate to severe dia-
stolic dysfunction did not increase early mortality.10 How-
ever, to our knowledge, the prognostic value of moderate to
severe diastolic dysfunction in terms of long-term outcome
evaluated with Doppler echocardiography has not been
studied. We therefore investigated the long-term outcome of
severe aortic stenosis and the importance of preoperative
left ventricular function, LVM, and prosthesis type (me-
chanical or biologic) and size in consecutive patients. Be-
cause the prognostic importance of these parameters can be
expected to change with time, we applied a special statisti-
cal method (Poisson regression) that enabled us to evaluate
temporal changes in risk prediction.
Methods
Subjects
Between January 1991 and December 1993, a total of 648 patients
from western Sweden were admitted to Sahlgrenska University
Hospital for aortic valve replacement. We excluded 195 patients
with a maximum gradient less than 60 mm Hg and a calculated
effective orifice area greater than 1.0 cm2, more than moderate
(grade 2/4) aortic or mitral regurgitation, or signs of mitral
stenosis. Fifty-four patients with incomplete preoperative data
were excluded. The echocardiographic investigations of the re-
maining 399 patients were reevaluated by two experienced exam-
iners. The mortality during the 12-year follow-up period was
investigated, and death certificates were collected through the
Swedish National Board of Health and Welfare. The study was
approved by the human ethics committee at Sahlgrenska Univer-
sity Hospital.
M-mode and 2-Dimensional Echocardiography
Preoperative echocardiography was performed with an Acuson
128 or 128XP Computed Sonograph (Acuson Corporation, Moun-
tain View, Calif). M-mode measurements were made according to
the recommendations of the American Society of Echocardiogra-
phy. LVM was calculated with the cube formula,11 and the left
ventricular ejection fraction (LVEF, [diastolic volumesystolic
volume]/diastolic volume  100%) was calculated either accord-
The Journal of Thoraciing to the Simpson rule or according to Teichholtz. In patients in
whom the LVEF could not be calculated, a visual estimation of the
LVEF was made (performed in 7% of cases). Planimetry of the left
atrium was performed on line from a late systolic stop frame. The
left ventricular outflow tract diameter was measured from a
parasternal long-axis view.
Doppler Measurements
Blood flow velocity in the left ventricular outflow tract was esti-
mated by pulsed-wave Doppler from an apical four-chamber view.
Mitral flow was recorded between the mitral leaflets in the four-
chamber view. From the mitral velocity tracings, early flow ve-
locity (E), the deceleration time of E wave, and peak velocity
during atrial systole (A) were measured. The E/A ratio was calcu-
lated. Pulmonary venous flow velocities were obtained from the
upper right pulmonary vein. Peak velocities during systole (S) and
diastole (D) were measured. The S/D ratio was calculated. Con-
tinuous wave Doppler signals were recorded from multiple win-
dows. The stroke volume was calculated as the product of the
cross-sectional area of the left ventricular outflow tract and the
velocity time integral. Pressure gradients were calculated accord-
ing to the simplified Bernoulli equation, and the effective orifice
area was calculated according to the continuity principle.
Patterns Describing Diastolic Function
The diastolic function was evaluated by integrating mitral flow and
pulmonary venous information.12 Four different filling patterns
were described: type A, normal diastolic function (normal mitral
E/A and S/D ratios); type B, mild diastolic dysfunction (reduced
E/A ratio and normal S/D ratio); type C, moderate diastolic dys-
function (normal E/A ratio [pseudonormalization] and reduced
S/D ratio); and type D, severe diastolic dysfunction (increased E/A
ratio and reduced S/D ratio). The patients were then divided into
two groups: those with normal diastolic function to mild diastolic
dysfunction (types A and B), who are likely to have normal filling
pressure, and those with moderate to severe diastolic dysfunction
(types C and D), who often have increased left ventricular filling
pressure.12 The graded assessment of diastolic function requires
sinus rhythm, and patients with atrial fibrillation were therefore
excluded. The mitral and pulmonary venous flow patterns are age
dependent. A healthy control group (n 71, age 18-83 years, 59%
men) without hypertension or diabetes mellitus, with a normal
resting electrocardiogram, and without a history of heart disease
was compared with the study group.
Statistical Analyses
Continuous variables are expressed as mean  SD. Categoric
variables are summarized with the use of proportions. The mean of
3 M-mode and Doppler measurements was used in patients with
sinus rhythm and the mean of 5 measurements was used in patients
with atrial fibrillation. An unpaired Student t test was used to
compare continuous data, whereas the 2 test was used to compare
categoric data.
The death hazard function was estimated with a Poisson model
depending on a set of variables.13 With this model, it is possible to
evaluate the prognostic importance of a variable and evaluate
whether it changes with time. The hazard function was of the form
exp(0  1x1  2x2  . . .  kxk), where 1, 2, . . ., k were
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quantity exp() gives the hazard ratio (HR) of a difference of 1
unit of the corresponding variable. The analysis was performed in
stepwise fashion. The following variables were included: age, sex,
time since surgical treatment, LVEF, normal diastolic function to
mild diastolic dysfunction (value of 0) versus moderate to severe
diastolic dysfunction (value of 1), prosthesis type, prosthesis size,
and LVM. In the last step, only the variables of significant impor-
tance (P  .05) were included.
Diastolic function parameters are known to be age dependent.
From the healthy control subjects, a regression equation including
age was calculated, as well as the residuals. For each patient in the
study group, the expected E/A ratio and S/D ratio were predicted.
The observed E/A ratios and S/D ratios in patients were regarded
as being reduced or increased if they differed by more than 1.96
SD from the predicted value by Z score.
Results
Clinical and Echocardiographic Characteristics
The age at the time of operation was 71 9 years, and 45%
of the patients were women. Only 2.5% of the patients were
younger than 50 years (10/399), whereas 12.5% were
younger than 60 years (50/399). Forty percent underwent
combined aortic valve replacement and coronary artery by-
pass grafting procedures, and 16% had atrial fibrillation.
Thirty percent (n  118) received a stented biologic pros-
thesis (Biocor; St Jude Medical Inc, Minneapolis, Minn)
and, among those who received a mechanical prosthesis (n
 279), 228 patients received a St Jude Medical Standard
prosthetic valve (St Jude Medical Inc), 45 an OmniCarbon
(Medical Incorporated, Inver Grove Heights, Minn), and 5 a
Carbomedics (Sulzer Carbomedics Inc, Austin, Tex). The
mean size of the biologic prosthesis was 24  1.6 mm; that
of the mechanical prosthesis was 22.8  2.2 mm. Thirty-
one percent received a small prosthesis (21 mm), and only
8 patients received a stented biologic valve of size 21.
Twenty-four percent of the patients had a reduced LVEF
(50%), 30% had moderate to severe diastolic dysfunction,
TABLE 1. Mortality risk estimated by a Poisson model
including age, sex, different time intervals, and diastolic
function
 SE P value
Constant 6.99 1.00 .0001
Current age 0.09 0.01 .0001
Sex 0.21 0.17 .23
Min(time, 1/12)* 23.6 7.09 .0009
Max[min(time-1/12, 0.5-1/12), 0]† 3.48 1.41 .01
Max(time-0.5, 0)‡ 0.12 0.03 .0005
Moderate to severe diastolic dysfunction 0.54 0.18 .0023
*Reflecting change in risk per year during first month after surgery.
†Reflecting change in risk per year during second through sixth months
after surgery.
‡Reflecting change in risk per year at more than 6 months after surgery.and another 12% had mild diastolic dysfunction.
892 The Journal of Thoracic and Cardiovascular Surgery ● ApriThe median follow-up was 9.4 years (range 0-12 years).
The overall survival after 12 years was 50%. The early
(30 days) mortality was 4% (n  17). Autopsy was
performed on 15 patients who died during follow-up (8%).
Mortality Risk
The mortality risk was markedly reduced during the initial
6-month period, but it then increased more than could be
explained by age (Table 1). The yearly increase in mortality
risk was 12% (HR of 1-year difference 1.12, P  .0005).
Moderate to severe diastolic dysfunction was identified as
an independent predictor (HR 1.72, P  .0038). Patients
with moderate to severe diastolic dysfunction had a 72%
increase in mortality risk relative to those with normal
diastolic function or mild dysfunction. LVEF did not inde-
pendently predict mortality (HR 0.99, P  .18) but contrib-
uted significantly (HR 0.986, P  .0038) when moderate to
severe diastolic dysfunction was omitted from the regres-
sion model. Figure 1 shows the importance of increased
moderate to severe diastolic dysfunction and age.
The effect of preoperative moderate to severe diastolic
dysfunction on the mortality risk did not decrease with time
(Table 2). On the contrary, there was a tendency for the
importance of preoperative dysfunction to increase with
time. Figures 2 and 3 are based on the results of the Poisson
model presented in Table 2. For a 65-year-old woman with
preoperative moderate to severe diastolic dysfunction, there
was a tendency for the annual incidence of death to increase
(Figure 2). For patients with normal diastolic function to
mild dysfunction, the probability of survival did not differ
from that of the general population after the first six-month
period (Figure 3). For patients with moderate to severe
diastolic dysfunction, however, the probability of survival
continued to deviate from that of the general population.
The estimated risk ratio for death between moderate to
severe diastolic dysfunction and normal diastolic function to
mild dysfunction was 1.60 after 2 years; it increased to 1.90
after 10 years.
LVM did not predict mortality (P .42), nor did pros-
thesis type (P  .42) or size (P  .58). We hypothesized
that the combination of left ventricular hypertrophy and
small prosthesis size or biologic prosthesis could adversely
influence mortality, but these high P values excluded any
interaction, and further analyses were not performed.
Left Ventricular Diastolic Function
Patients with moderate to severe diastolic dysfunction were
older, with a lower LVEF and cardiac output (Table 3)
compared with others. Patients with moderate to severe
diastolic dysfunction had a larger left atrium and a higher
systolic tricuspid valve gradient, indicating higher pulmo-
nary arterial pressure. The percentages of biologic prosthe-
l 2005
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dures did not differ.
Discussion
To our knowledge, this study represents the first large series
of patients with severe aortic stenosis undergoing aortic
Figure 1. Importance of moderate to severe diastolic dysfunction
(bold lines) compared with normal diastolic function to mild
dysfunction (narrow lines) and age at entry for probability of
death within 1 year, 5 years, and 10 years. A, Results for men. For
a 70-year-old male patient, probability of death within 10 years
increases from approximately 35% with normal diastolic function
to mild dysfunction to 53% in those with moderate to severe
diastolic dysfunction. B, Results for women. For a 70-year-old
female patient, probability of death within 10 years increases
from approximately 30% with normal diastolic function to mild
dysfunction to 47% in those with moderate to severe diastolic
dysfunction.valve replacement in which the importance of preoperative
The Journal of Thoracidiastolic dysfunction has been investigated. As a major
finding of potential clinical importance, we found that mod-
erate to severe diastolic dysfunction estimated from Doppler
echocardiography was an independent risk factor for late
total mortality. The importance of preoperative moderate to
severe diastolic dysfunction did not decrease with time. This
finding suggests that moderate to severe diastolic dysfunc-
tion in patients with severe aortic stenosis is indicative of
nonreversible structural myocardial changes that negatively
Figure 2. Risk of death associated with normal diastolic function
to mild dysfunction or moderate to severe diastolic dysfunction
compared with the general population. Curves show risk for a
woman 65 years old at operation. Bold line indicates moderate to
severe diastolic dysfunction; narrow line indicates normal dia-
stolic function to mild dysfunction; dashed line indicates general
population.
TABLE 2. The importance of preoperative diastolic dys-
function and time for mortality risk estimated by a Poisson
model
 SE P value
Constant 6.95 1 .0001
Current age 0.09 0.01 .0001
Gender 0.219 0.17 .23
Min(time, 1/12)* 23.69 7.09 .0009
Max[min(time-1/12, 0.5-1/12), 0]† 3.51 1.41 .01
Max(time-0.5, 0)‡ 0.11 0.04 .005
Moderate to severe diastolic
dysfunction
0.43 0.32 .19
Moderate to severe diastolic
dysfunction times time
0.02 0.05 .67
*Reflecting change in risk per year during first month after surgery.
†Reflecting change in risk per year during second through sixth months
after surgery.
‡Reflecting change in risk per year at more than 6 months after surgery.affect survival.
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Interestingly, in this study, the LVEF did not independently
predict the long-term outcome when diastolic function was
considered. We can see two reasons for this. First, studies of
systolic and diastolic function in patients with aortic steno-
sis show that diastolic dysfunction dominates9,14 and prob-
ably precedes changes in myocardial contractility.14 Hess
and colleagues15 demonstrated that 50% of patients with
aortic stenosis had signs of diastolic dysfunction, despite
normal systolic function. In this study, 24% of patients had
an LVEF less than 50%, but 30% had moderate to severe
diastolic dysfunction and another 12% had mild diastolic
dysfunction with signs of impaired relaxation. Second, from
previous studies of patients with pressure overload, we
know that a reduced LVEF often reflects the afterload
excess in patients with aortic stenosis, rather than true
myocardial contractile dysfunction.14,16
We divided the patients, according to recommenda-
tions,12 into four groups that reflected an increasing level of
disease. The different flow velocity patterns in the mitral
valve and pulmonary vein are primarily determined by the
pressure gradient between the atrium and left ventricle.
Patients with a normal left ventricular filling pattern or
impaired relaxation are likely to have normal left ventricular
compliance and normal left ventricular filling pressure. Pa-
Figure 3. Importance of normal diastolic function to mild dysfunc-
tion or moderate to severe diastolic dysfunction for probability of
survival. Curves were calculated from results of Poisson model in
Table 2. Bold line indicates moderate to severe diastolic dysfunc-
tion; narrow line indicates normal diastolic function to mild
dysfunction; dashed line indicates general population.tients with moderate to severe diastolic dysfunction are
894 The Journal of Thoracic and Cardiovascular Surgery ● Aprilikely to have decreased left ventricular compliance and
increased left ventricular filling pressure.12 It could be ar-
gued that the importance of preoperative diastolic dysfunc-
tion should decrease with time in response to regression in
myocardial hypertrophy and the normalization of myocar-
dial structure.17 In this study, we used a statistical method
that enabled us to evaluate the impact with time. Impor-
tantly, we found that preoperative moderate to severe dia-
stolic dysfunction indicated an unchanged or even increased
postoperative mortality risk. This finding suggests that mod-
erate to severe diastolic dysfunction in patients with aortic
stenosis indirectly reflects nonreversible structural myocar-
dial abnormalities that may eventually prove to be lethal.
Importance of Left Ventricular Hypertrophy and
Prosthetic Type and Size
The negative impact of left ventricular hypertrophy on
mortality among otherwise healthy individuals has been
documented.18 The aortic valve replacement procedure re-
duces left ventricular afterload, thereby starting a remodel-
ing process that goes on for several years19 and is prosthesis
gradient dependent.9 We hypothesized that among patients
undergoing aortic valve replacement there would be indi-
viduals with important residual LV hypertrophy and that
this might increase mortality. This was not the case, which
raises questions about the importance of the prosthesis-
patient mismatch issue.20 In this study, patients with narrow
aortic roots (size 19 or 21) received a mechanical prosthetic
valve whenever possible to avoid the risk of prosthesis-
patient mismatch with small stented biologic valves. This
policy may have influenced the outcome, and we know from
a study of a subgroup of these patients that those with
prosthesis sizes 19 and 21 also had a reduction in LVM after
2 years.9 Our patients consisted of an elderly, less active
population. To recognize problems related to prosthesis-
patient mismatch, the study group and the number of indi-
viduals with high activity levels should be larger, and the
end point should include quality of life parameters. So,
despite the important finding that the prosthesis size did not
influence the long-term outcome in terms of mortality, we
do not interpret our results as an argument against the
prosthesis-patient mismatch problem.
In this study, we were not able to demonstrate any
differences in outcome related to prosthesis type. We know
from randomized trials comparing mechanical and biologic
valves in the aortic position that problems with the biologic
valve from valve deterioration start 10 to 12 years after the
operation.21,22 After 20 years of follow-up, Oxenham and
associates22 were not able to demonstrate any differences in
mortality between groups with mechanical and biologic
prosthetic valves. When reoperation or death was used as an
end point, however, the mechanical prosthetic valve had a
better outcome. Our results, in terms of survival after 12
years of follow-up, therefore agree with those of other
l 2005
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care.
Limitations
First, diastolic function was not evaluated with invasive
catheter measurements, which is the criterion standard. We
used different mitral and pulmonary vein filling patterns to
grade the severity of diastolic dysfunction; although well
documented, this is an indirect and categoric method.12
Because of technical difficulties, we were not able to mea-
sure the isovolumetric relaxation time or the duration of the
flow reversal during atrial systole in the pulmonary vein.
Adding these parameters might have improved the grading
of severity.23 Second, we assumed that moderate to severe
diastolic dysfunction represented intrinsic myocardial prop-
erties related to possible negative effects on outcome. To
our knowledge, there are no reports on the correlation
between the Doppler echocardiographic grading of diastolic
function and myocardial composition or histopathologic
changes in patients with aortic stenosis. even if these as-
sumptions have not been proved or validated, however, the
important message is that the left ventricular filling pattern
studied with Doppler echocardiography contains important
prognostic information.
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